Part Number : ULTRASE MT20 | Manufacturer : Axcan Pharma Us Inc | ||
NSN : 6505-01-360-5739 (6505013605739) | |||
Item Name : Pancrelipase Deleayed Release Ca | CAGE Code : 0TX62 | ||
NIIN : 01-360-5739 (013605739) | |||
INC Code : 66747 | |||
NCB Code : 01 | Country : USA |
Thank you for taking an interest in part number ULTRASE MT20, that of which is listed with the description Pancrelipase Deleayed Release Ca; Manufactured by Axcan Pharma Us Inc and listed alongside the NSN 6505013605739, part number ULTRASE MT20 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
Part Number : ULTRASE MT20 | Manufacturer : Axcan Pharma Us Inc | ||
NSN Number : 6505-01-360-5739 (6505013605739) | |||
Item Name : Pancrelipase Deleayed Release Ca | CAGE Code : 0TX62 | ||
NIIN : 013605739 |
Thank you for taking an interest in part number ULTRASE MT20, that of which is listed with the description Pancrelipase Deleayed Release Ca; Manufactured by Axcan Pharma Us Inc and listed alongside the NSN 6505013605739, part number ULTRASE MT20 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
---|---|---|---|---|---|---|
6505-01-360-5739 Item Description: Pancrelipase Deleayed Release Ca | 6505 | 013605739 | M | P | ||
CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
U | A | |||||
Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
Ultrase Mt20 | 5 | 1 | 5 |
MRC | Criteria | Characteristic |
---|---|---|
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | PANCRELIPASE DELAYED-RELEASE CAPSULES 100S BT |
AKJC | CAPSULE TYPE | ANY ACCEPTABLE |
CQLS | CAPSULE CONTENT FORM | ANY ACCEPTABLE |
CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100 |
FEAT | SPECIAL FEATURES | CONTAINS 20,000 USP UNITS LIPASE ACTIVE INGREDIENT,65,000 USP UNITS AMYLASE ACTIVE INGREDIENT AND 65,0000 USP UNITS PROTEASE ACTIVE INGREDIENT; ENTERIC COATED |
CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
We hope that you will visit us again the next time you need board-level components, aviation and aerospace parts, and more. Allow us to serve as your strategic purchasing partner.
Request for Quote